Genomics Collaborative Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
35
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$14.3M
Genomics Collaborative General Information
Description
Developer of an integrated discovery platform to transform the next stage of genomic and proteomic discovery. The company provides clinical samples and develops methods for application of human genetics to target validation for drug discovery. It offers GCI platforms including GCI Discovery and Global Repository which would help in expediting drug discovery and improvements in diagnosis, prediction, prevention, and treatment of disease.
Contact Information
Corporate Office
- 99 Erie Street
- Cambridge, MA 02139
- United States
Corporate Office
- 99 Erie Street
- Cambridge, MA 02139
- United States
Genomics Collaborative Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 03-Jun-2004 | $14.3M | Completed | Pre-Clinical Trials | ||
| 5. Later Stage VC (Series E) | 11-Nov-2002 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series D) | 12-Oct-2000 | Completed | Product Development | |||
| 3. Later Stage VC (Series C) | Completed | |||||
| 2. Early Stage VC (Series B) | $2.2M | $4.2M | Completed | |||
| 1. Early Stage VC (Series A) | $2M | $2M | Completed | Product Development |
Genomics Collaborative Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 1,543,225 | $0.010000 | 9% | $1.43 | $0.11 | 0x | $1.43 | 1.33% |
| Series A | 4,200,000 | $0.010000 | 9% | $0.48 | $0.08 | 0x | $0.48 | 3.61% |
Genomics Collaborative Patents
Genomics Collaborative Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20030022191-A1 | Diagnosing mammary gland cancer in humans, obtain tissue sample, extract nucleotide sequence, amplify, electrophorese, incubate with probe, monitor pattern, detect polymorphisms | Inactive | 08-Jan-2001 | ||
| AU-2002241821-A1 | Method of detecting polymorphisms associated with breast carcinoma in mhc genes | Inactive | 08-Jan-2001 | ||
| WO-2002053018-A2 | Method of detecting polymorphisms associated with breast carcinoma in mhc genes | Inactive | 08-Jan-2001 | ||
| WO-2002053018-A3 | Method of detecting polymorphisms associated with breast carcinoma in mhc genes | Inactive | 08-Jan-2001 | ||
| WO-2002031194-A1 | Method of diagnosing and treating increased risk of death from community-acquired pneumonia associated with the a allele of the tnfα-238 polymorphism | Inactive | 10-Oct-2000 | C12Q1/6883 |
Genomics Collaborative Signals
Genomics Collaborative Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flagship Pioneering | Venture Capital | Minority | ||
| Invesco | Asset Manager | Minority | ||
| Oracle Capital Partners | PE/Buyout | Minority | ||
| Singapore Economic Development Board | Government | Minority | ||
| Whitney & Company | Asset Manager | Minority |
Genomics Collaborative FAQs
-
When was Genomics Collaborative founded?
Genomics Collaborative was founded in 1998.
-
Where is Genomics Collaborative headquartered?
Genomics Collaborative is headquartered in Cambridge, MA.
-
What is the size of Genomics Collaborative?
Genomics Collaborative has 35 total employees.
-
What industry is Genomics Collaborative in?
Genomics Collaborative’s primary industry is Drug Discovery.
-
Is Genomics Collaborative a private or public company?
Genomics Collaborative is a Private company.
-
What is the current valuation of Genomics Collaborative?
The current valuation of Genomics Collaborative is .
-
What is Genomics Collaborative’s current revenue?
The current revenue for Genomics Collaborative is .
-
How much funding has Genomics Collaborative raised over time?
Genomics Collaborative has raised $57.6M.
-
Who are Genomics Collaborative’s investors?
Flagship Pioneering, Invesco, Oracle Capital Partners, Singapore Economic Development Board, and Whitney & Company have invested in Genomics Collaborative.
-
When was Genomics Collaborative acquired?
Genomics Collaborative was acquired on 03-Jun-2004.
-
Who acquired Genomics Collaborative?
Genomics Collaborative was acquired by SeraCare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process